Skip to search formSkip to main contentSkip to account menu

NEO100

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

perillyl alcohol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models.
OBJECTIVEMany pharmaceutical agents are highly potent but are unable to exert therapeutic activity against disorders of the… 
2020
2020
Inhibition of motility by NEO100 through the calpain-1/RhoA pathway.
OBJECTIVE Glioblastoma (GBM) is the most aggressive type of brain tumor with a high rate of tumor recurrence, and it often… 
2020
2020
Erratum. Inhibition of motility by NEO100 through the calpain-1/RhoA pathway.
2019
2019
Abstract CT064: Intranasal brain delivery using NEO100 for recurrent glioblastoma
NO CHANGES TO ORIGINAL ABSTRACT NEO100 is a GMP quality, purified perillyl alcohol (POH) which has been undergoing clinical… 
2018
2018
CADD-56. INTRA-ARTERIAL NEO100 TRANSIENTLY OPENS THE BLOOD BRAIN BARRIER
Review
2015
Review
2015
Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.
Perillyl alcohol (POH) is a naturally occurring dietary monoterpene isolated from the essential oils of lavender, peppermint, and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)